Healthcare · Biotech & Pharma
Colossal Biosciences
Series C
Implied valuation
$00 B
Live tracking
IPO Odds00 %modeled estimate
Probability modeled from funding stage, momentum & liquidity signals.
Valuation Trajectory
1.4K×
since foundingJun 2016Jun 2026
Funding-round staircase from founding · log scale. Modeled round ladder anchored to the current valuation — illustrative, not a published figure.
IPO Model Drivers
Why the odds read this way
Valuation momentum
+22.5% trailingFinancing stage
Series CScale & liquidity pull
Private-market valuationFactor weights are illustrative decompositions of the modeled IPO probability, not guarantees.
Down-Round Risk
Valuation downside pressure
Moderate
Mixed signals — limited valuation history with 32% modeled IPO odds keep down-round risk in the middle band.
Asset brief
Colossal Biosciences is a Healthcare · Biotech & Pharma company last marked at $10.32B. Stage: Series C. No verified market-moving events in the last 30 days.
Capital Timeline
Funding & liquidity milestones
Series C
$10.32B
Backed by
No disclosed investors yet.
Comparables
Healthcare
Signals
No recent signals for Colossal Biosciences.